Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 210.3% in December

Aclarion, Inc. (NASDAQ:ACON) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 1,230,000 shares, a growth of 210.3% from the November 30th total of 396,400 shares. Approximately 11.8% of the company’s stock are short sold. Based on an average daily trading volume, of 650,100 shares, the days-to-cover ratio is currently 1.9 days.

Aclarion Trading Down 0.2 %

NASDAQ ACON opened at $0.14 on Friday. The company has a fifty day moving average price of $0.17 and a 200-day moving average price of $0.22. Aclarion has a 1 year low of $0.10 and a 1 year high of $6.75.

Analyst Ratings Changes

Several equities research analysts have recently commented on ACON shares. Maxim Group reissued a “hold” rating on shares of Aclarion in a research report on Friday, December 13th. Ascendiant Capital Markets lowered their price objective on Aclarion from $1.50 to $1.30 and set a “buy” rating for the company in a research note on Wednesday, November 27th.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.